{
  "zip": "37932",
  "sector": "Healthcare",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing drugs based on halogenated xanthenes for oncology, hematology, and dermatology indications. Its prescription drug candidates include PV-10, which is in Phase Ib/II study for metastatic melanoma; Phase I study for hepatocellular carcinoma and other solid tumors metastatic to the liver; and non-clinical assessment of pediatric cancer tumor cell. The company is also developing PH-10 that has completed Phase II randomized study for the treatment of psoriasis and atopic dermatitis. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee.",
  "city": "Knoxville",
  "phone": "866 594 5999",
  "state": "TN",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.provectusbio.com",
  "maxAge": 1,
  "address1": "10025 Investment Drive",
  "fax": "866 998 0005",
  "industry": "Biotechnology",
  "address2": "Suite 250",
  "previousClose": 0.0698,
  "regularMarketOpen": 0.0675,
  "twoHundredDayAverage": 0.07023741,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.075,
  "navPrice": null,
  "averageDailyVolume10Day": 502100,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0698,
  "fiftyDayAverage": 0.06160606,
  "trailingAnnualDividendRate": null,
  "open": 0.0675,
  "averageVolume10days": 502100,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.603466,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0675,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 363124,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 27507366,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 329707,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0675,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 363124,
  "fiftyTwoWeekHigh": 0.13,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.03,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.075,
  "exchange": "PNK",
  "shortName": "PROVECTUS BIOPHARMACEUTICALS IN",
  "longName": "Provectus Biopharmaceuticals, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "PVCT",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_2336891",
  "uuid": "78df7f78-a595-3c43-b870-cae89f7acd84",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -11.123,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 400982016,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.072,
  "sharesShort": 1821793,
  "sharesPercentSharesOut": 0.0075,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.0005,
  "netIncomeToCommon": -6561623,
  "trailingEps": -0.017,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.04533,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 0.47,
  "sharesShortPreviousMonthDate": 1472601600,
  "floatShares": 382621070,
  "enterpriseValue": 50560364,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1018483200,
  "lastSplitFactor": "1:300",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1475193600,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0078,
  "sharesShortPriorMonth": 2858468,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0675,
  "logo_url": "https://logo.clearbit.com/provectusbio.com"
}